The p53 protein is a critical participant in a signal transduction pat
hway which mediates a G, cell cycle arrest and apoptotic cell death in
mammalian cells after ionizing irradiation. Cells from patients with
the cancer-prone, radiation-sensitive disorder, ataxia-telangiectasia
(AT), exhibit suboptimal (delayed and/or defective) induction of p53 p
rotein after ionizing radiation with some dependence on dose. Other pr
otein products which participate in this signal transduction pathway,
including p21(WAF1/CIP1), Gadd45, and Mdm2, are also suboptimally indu
ced in AT cells after ionizing radiation. Induction of p53 is also abn
ormal in AT cells following treatment with methylmethanesulfonate and
bleomycin but appears relatively normal following treatment with W-C i
rradiation or the topoisomerase inhibitors, etoposide and camptothecin
. These results demonstrate a specific defect in this p53-dependent si
gnal transduction pathway in AT cells. Potential models for this obser
ved specificity of the AT defect as measured by p53 induction include
problems with responses to: (a) single-strand, but not double-strand,
DNA breaks; or (b) chemically, but not enzymatically, generated DNA en
ds.